practolol has been researched along with Substance Withdrawal Syndrome in 7 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The possible adverse effects of treatment during pregnancy are also considered." | 2.36 | Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions. ( Beeley, L; Kendall, MJ, 1983) |
| " Adverse and potentially specific reactions to individual beta-blocking agents." | 2.36 | Side effects and contraindications of beta-receptor blocking agents. ( Lydtin, H, 1977) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| "When propranolol and morphine were administered concurrently the morphine ED50 (on day 5) was twice that of the group receiving morphine alone." | 1.25 | Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys. ( Cowan, A; Macfarlane, IR, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kendall, MJ | 1 |
| Beeley, L | 1 |
| Wall-Manning, HJ | 1 |
| Cowan, A | 1 |
| Macfarlane, IR | 1 |
| Fitzgerald, JD | 1 |
| Lydtin, H | 1 |
| Frishman, W | 1 |
| Silverman, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Raman, G | 1 |
| Ahmed, M | 1 |
2 reviews available for practolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
Topics: Adrenergic beta-Antagonists; Bradycardia; Brain; Drug Eruptions; Drug Interactions; Eye Diseases; Fe | 1983 |
Side effects and contraindications of beta-receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Arrhythmias, Cardiac; Blood Vessels; Central | 1977 |
5 other studies available for practolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Problems with practolol.
Topics: Adrenergic beta-Antagonists; Cross Reactions; Eye Diseases; Heart Diseases; Humans; Peritonitis; Pra | 1975 |
Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys.
Topics: Analgesics, Opioid; Animals; Drug Interactions; Drug Tolerance; Female; Haplorhini; Humans; Macaca m | 1975 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Amelioration of withdrawal symptoms in morphine addicted albino rats.
Topics: Animals; Cyclic AMP; Humans; Insulin; Morphine Dependence; Practolol; Rats; Substance Withdrawal Syn | 1977 |